Blog
RSS FeedPosted by Michael Wonder on 12 Apr 2025
Public Summary Documents – December 2024 PBAC meeting
11 April 2025 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the December 2024 PBAC ...
Posted by Michael Wonder on 02 Apr 2025
Agenda for the July 2025 PBAC meeting
2 April 2025 - The agenda for the July 2025 PBAC meeting is now available. ...
Posted by Michael Wonder on 21 Mar 2025
Public Summary Documents (first time rejections and deferrals)– November 2024 PBAC meeting
21 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 07 Mar 2025
Public Summary Documents – November 2024 PBAC meeting
7 March 2025 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2024 PBAC ...
Posted by Michael Wonder on 17 Feb 2025
Unravelling the association between uncertainties in model-based economic analysis and funding recommendations of medicines in Australia
14 February 2025 - Health technology assessment is used extensively by the PBAC to inform medicine funding recommendations in Australia. ...
Posted by Michael Wonder on 02 Feb 2025
Public consultation: draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP
31 January 2025 - Consultation on the draft 2025-26 cost recovery implementation statement for listing medicines on the PBS and ...
Posted by Michael Wonder on 31 Jan 2025
Outcomes from the December 2024 PBAC meeting
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 27 Dec 2024
Bureaucratic ‘deficiencies’ in medicine funding underscore access crisis
26 December 2024 - The Government’s independent medicine funding assessor, still recovering from a public failure to process months worth ...
Posted by Michael Wonder on 24 Dec 2024
Public Summary Documents – September 2024 PBAC meeting
24 December 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2024 PBAC ...
Posted by Michael Wonder on 23 Dec 2024
Update from the PBAC (December 2024)
23 December 2024 - An update from the Chair and Deputy Chair of the PBAC is now available. ...
Posted by Michael Wonder on 20 Dec 2024
Recommendations made by the PBAC – November 2024
20 December 2024 - Recommendations made by the PBAC in November 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 18 Dec 2024
Agenda for the May 2025 PBAC meeting
18 December 2024 - The agenda for the May 2025 PBAC meeting is now available. ...
Posted by Michael Wonder on 12 Dec 2024
Outcome statements for October 2024 stakeholder meetings: oral contraceptives and migraine
9 December 2024 - The Outcome Statements are now available for the Oral Contraceptives Stakeholder Meeting held on 10 October 2024 ...
Posted by Michael Wonder on 10 Dec 2024
Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2 billion Morrison era deal
10 December 2024 - Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems. ...
Posted by Michael Wonder on 07 Dec 2024
2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP
4 December 2024 - The PBS and NIP Cost Recovery Implementation Statement has been updated to include 2023-24 end of ...